Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness.
Julia C F QuintanilhaMichael H StorandtRyon P GrafGerald LiRachel B KellerDouglas I LinJeffery S RossRichard S P HuangAlexa B SchrockGeoffrey R OxnardSakti CjakrabartiAmit MahipalPublished in: JCO precision oncology (2023)
mutation among patients with PDAC and high-TMB, which to our knowledge, is a novel finding.